Middle East & Africa Veterinary Healthcare Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis

The Middle East & Africa Veterinary Healthcare Market is projected to grow significantly, reaching an estimated US$ 3,211.9 million by 2031, up from US$ 2,036.3 million in 2024, reflecting a compound annual growth rate (CAGR) of 6.7% from 2025 to 2031. This growth is primarily driven by the increasing prevalence of livestock diseases and enhanced government funding aimed at bolstering the veterinary healthcare sector.

The market is segmented into various regions, including Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East & Africa (MEA). Notably, South Africa held the largest market share in 2024, attributed to rising pet ownership, heightened awareness of veterinary healthcare, and proactive initiatives by companies in the region. For instance, in April 2025, BioChek Group expanded its operations into South Africa by establishing a new office in Johannesburg, targeting the broader Sub-Saharan market.

In terms of animal type, the market is divided into Companion Animals and Livestock & Poultry, with Livestock and Poultry dominating the market share in 2024. Within the Companion Animal segment, dogs represented the largest share, while in the Livestock and Poultry category, poultry was the leading segment. The market is also categorized by product type, with Pharmaceuticals, Medical Devices, and Feed Additives, where Pharmaceuticals held the largest share in 2024. Furthermore, the Pharmaceuticals segment is subdivided into Antimicrobials, Parasiticides, Vaccines, and others, with the 'Others' category leading in market share.

Technological advancements are reshaping the veterinary healthcare landscape, introducing trends that enhance diagnosis, treatment, and overall animal care. The integration of artificial intelligence (AI) is particularly transformative, improving diagnostics, treatment planning, and drug discovery. For example, in February 2025, researchers in Saudi Arabia developed an AI-powered diagnostic model for falcon diseases, utilizing advanced architectures to classify conditions such as liver disease and aspergillosis. This innovation not only demonstrates the region's commitment to modern veterinary practices but also enhances diagnostic accuracy and treatment outcomes.

Moreover, advancements in drug delivery systems are significantly improving treatment effectiveness. Innovations such as nanoparticle formulations enable targeted drug release, while long-acting injectables reduce the frequency of treatments. Additionally, transdermal patches provide a minimally invasive administration method, enhancing patient comfort and compliance. The development of new vaccine delivery methods, including oral vaccines and needle-free injectors, is also improving convenience for pet owners and livestock producers. For instance, Boehringer Ingelheim's oral rabies vaccine has been widely used in wildlife management, showcasing the potential of novel delivery systems.

The market is also witnessing improvements in diagnostic technologies that facilitate early disease detection, which is crucial for managing chronic conditions in pets. The use of next-generation sequencing (NGS) technology is advancing companion animal diagnostics by allowing rapid analysis of multiple genes, aiding in the identification of genetic mutations linked to specific diseases. This technology has also enabled the development of sensitive diagnostic tests for cancer and hereditary diseases, further enhancing veterinary care.

By country, the market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of the MEA, with South Africa leading in market share in 2024. The continent boasts a substantial population of both livestock and companion animals, and organizations like the South African Animal Health Association and the World Organization for Animal Health are actively promoting animal health and research. Initiatives such as the Vaccination Guidelines Group (VGG) project launched by the World Small Animal Veterinary Association aim to improve understanding of infectious diseases and vaccination importance in Sub-Saharan Africa. Additionally, Gavi's African Vaccine Manufacturing Accelerator (AVMA) initiative, which aims to invest up to US$ 1.2 billion over ten years, is set to bolster Africa's vaccine manufacturing capabilities.

Key players in the Middle East & Africa Veterinary Healthcare Market include Merck & Co., Inc., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Zoetis Inc, Elanco Animal Health Inc, Idexx Laboratories Inc, Neogen Corp, HIPRA SA, Shenzhen Mindray Animal Medical Technology Co., LTD, and Antech Diagnostics, Inc. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.